Clinical Trial Update: A Study of MRG002 in the Treatment of Patients With HER2-low Locally Advanced or Metastatic Breast Cancer (BC) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for MRG002 in HER2-low locally advanced or metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• MRG002

Snippet

Sponsor: Shanghai Miracogen Inc. | Conditions: Advanced or Metastatic Breast Cancer | Phase 2 | Status: UNKNOWN